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In  the  course  of  studies  on  hemolytic streptococci  derived  from  human 
sources,  Ward  and  Rudd  (1)  in  1938 encountered certain  Group A  strains 
which gave rise to a marked opalescence when grown in a medium rich in horse 
serum. The opalescence, which the authors believed to be a result of enzymic 
denaturation of serum protein, could be reproduced in rabbit, mouse, or human 
sera by Seitz filtrates of serum-broth cultures of the active strains. The factor 
responsible for opalescence was shown to be heat-labile and inhibited by KCN. 
Krumwiede (2),  investigating this phenomenon a number of years later, found 
the  opalescence-producing principle  to be  a  cellular component of Group A 
streptococci, extractable from washed cells with the aid of concentrated solu- 
tions of urea.  Using  these  extracts,  she showed by means of paper  electro- 
phoresis  that  opalescence  is  accompanied  by  a  particular  alteration in  the 
electrophoretic distribution of serum lipids; i.e.,  by a  shift in lipid from the 
region of arglobulin to the region of O-globulin or the origin. No change in the 
concentration of the several classes of serum lipids was detected, nor was any 
change observed in the electrophoretic pattern of the serum proteins. Krum- 
wiede  suggested  that  the  extracts  contained  an  enzyme,  termed  "lipopro- 
teinase," which initiated opalescence by splitting a~-lipoprotein into its lipid 
and protein moieties. Rowen and Bernheimer (3)  subsequently found that an 
extract prepared by Krumwiede partially inactivated a streptolysin O inhibitor 
of lipoprotein nature found in mouse plasma following the intravenous adminis- 
tration of sublethal quantities of streptolysin O. 
Although the available evidence indicates that a factor produced by certain 
Group A streptococci can alter serum lipoproteins, to date there has been no 
report concerning the precise chemical nature of this alteration. The present 
investigation is an initial effort to elucidate the mechanism of action of the 
streptococcal factor that causes serum to become opalescent. 
* This investigation  was supported by a research grant (H-3261) from the National Heart 
Institute, United States Public Health Service. 
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Materials and Methods 
Streptococcal Extracts.--Extracts were prepared from a strain (2RP196) of Group A strep- 
tococcus Type  12  originally isolated from a  patient with rheumatic fever.  This strain was 
selected on the basis of preliminary tests made upon more than 100 Group A strains, most of 
which were kindly furnished by Dr.  Alan W.  Bernheimer; it sedimented rapidly upon cen- 
trifugation and yielded extremely potent extracts.  The organisms were grown at 37°C in 5 
fiter carboys of fresh beef heart infusion broth buffered at pH 7.8-8.0 and containing 4 per 
cent glucose,  0.2 per cent potassium bicarbonate, and 0.8 mg per cent phenol red.  The  glu- 
cose and bicarbonate were sterilized by Seitz filtration and added to the broth just prior to 
inoculation. Carboys of the complete medium, warmed to 37°C,  were inoculated in the early 
morning with 500 ml of  a  fresh overnight serum-broth culture  of  strain 2RP196,  and in- 
cubated at 37°C  for 8 to 10 hours with frequent neutralization of the acid  formed using 5 N 
NaOH.  Grown cultures were placed at 4°C overnight prior to harvesting and extracting the 
bacteria.  The separated  streptococci  (20 to 40 gm wet  weight)  from each 5  liter batch of 
culture were washed several times with cold 0.15 M NaC1 and extracted with 150 to 200 ml 
of 40 per cent urea in •  sodium acetate at pH  7.0.  The extraction and subsequent concen- 
tration of the extract generally followed the procedure outlined by Krumwiede (2). As a final 
step, extracts were dialyzed either against 0.1 ~  sodium acetate or 0.067 ~  phosphate buffer 
containing 0.08 *J NaC1 at pH 7.0, and stored at -20°C. Based on a crude opalescence titra- 
tion procedure, extracts stored in this way appeared to retain full activity for several years. 
Sera.--Fresh horse serum without preservative was generously supplied by Miss A. Walter 
of the Bureau of Laboratories, New York  City Department of Health.  Human serum was 
obtained aseptically from bleedings of apparently healthy young adults following an over- 
night fast. All sera were kept at 4°C until use (usually within 2 months) and every precaution 
taken to maintain strict asepsis during their storage and utilization. 
Ultracentrifugation.--Ultracentrifugal  fractionations of sera, to be more fully described in 
the experiments to follow,  were carried out at 16-18°C in a Spinco model L preparative ultra- 
centrifuge utilizing a  40.3 rotor. Material separated by flotation was recovered with the aid 
of a  Spinco tube-slicing device. 
Measurement  of  Opalescence.--Opalescence was  measured  as  the  difference  in  optical 
density at 540 mu between an incubated serum-extract mixture and a concurrently incubated 
serum-diluent control. In cases where opalescence of test mixtures was pronounced, suitable 
dilutions in  saline were  examined.  Readings  were  made  in  a  ]~eckman  DU  spectropho- 
tometer using standard cuvettes having a light path of 1 em. 
Chemical Determinations.--Free  and  total  cholesterol were  determined  by  the  modified 
Schoenheimer-Sperry procedure (4); values for cholesterol esters were obtained by multiplying 
the  difference between free  and total cholesterol by  1.68  (5).  Phospholipid was  estimated 
from lipid phosphorus measured by a  method similar to that of Stewart and Hendry  (6); a 
factor of 25 was used to convert the lipid phosphorus to phospholipid. Total lipid was meas- 
ured gravirnetrically after Folch extraction and purification of the lipid extract (7). Although 
specially constructed, extremely light weighing-shells were  used to minimize error, the lower 
limit of total lipid concentration that could be determined with reasonable accuracy was  10 
mg per cent. A micro-Kjeldahl procedure (8) was used for total nitrogen. 
Paper Electrophoresis.--To  observe the electrophoretic distribution of lipids in serum or 
serum fractions, samples were prestained with acetylated Sudan black B  following the pro- 
cedure recommended by McDonald and Berrnes (9); a slight modification was introduced to 
increase staining efficiency;  i.e., several additions of the alcoholic dye solution were made to 
the serum or fraction, with removal of alcohol in vacuo between each addition. 70 #1 of each 
prestained sample was applied to a  strip of Whatman 3MM paper and subjected to electro- 
phoresis in a Spinco Durrum-type cell, using veronal buffer at pH 8.6 and 0.05 ionic strength, 
and a constant current of 3 ma at room temperature for 6 hours. R.  ROWEN  809 
Lipid Chromatography.--Lipids  were chromatographed directly on silicic acid-impregnated 
paper without solvent extraction of the samples, according to the method of Marinetti and 
Stotz (10). Twenty-five #1 of each sample, containing 4 to 55/lg of total lipid,  was spotted 
on the paper. Ascending chromatograms were developed at 23°C with n-heptane:diisobutyl 
ketone  (96:6  v/v)  for  1  hour  (for  non-phospholipids), and  with  diisobutyl  ketone:acetic 
acid:water (40:20:3  v/v)  for 4 hours (for  phospholipids). The chromatograms were stained 
with rhodamine-6-G and examined for fluorescence  under ultraviolet light. To detect "ceph- 
alins," chromatograms were sprayed with a freshly prepared solution of ninhydrin in acetone- 
lutidine (9:1 v/v). 
EXPERIMENTAL 
The Separation  of Low Density Products Formed through lhe Action  of 
Streplococcal Extracts on Serum 
Proceeding  on  the  premise  that  the  opalescence  produced  in  serum  by 
streptococcal  extracts  might  be  due  to  low  density  lipids  or  lipid-protein 
complexes liberated  from  their  normal  associations with  serum  lipoproteins, 
an  experiment was undertaken  to  determine whether such products could be 
separated  from  extract-treated  sera  by  ultracentrifugal  flotation  at  normal 
serum density. 
TABLE  I 
Recovery by  Ultracentr{hlgal Flotation of Material  Responsible for  Opalescence in  Sera 
Incubated  with Streptococcal Extract 
Source  of serum 
Horse, No.  1-87 ................... 
Horse, No. 1-88 ................... 
Human, Gro ..................... 
Human, Ger ..................... 
Degree of opalescence* 
Unfractionated 
serum-extract 
mixture~ 
optical density  units 
1.01 
1.09 
1.07 
1.15 
Isolated low density 
fraction 
optical density  units 
1.01 
1.07 
0.98 
1.08 
Recovery 
per cenl 
100 
98 
92 
94 
* Difference in optical density at 540 mu between each mixture or fraction and the corre- 
sponding buffer control. 
3) Mixtures incubated at 37°C for 24 hours; final dilution of extract, 1:200. 
Samples of several human and horse sera were incubated for 24 hours at 37°C with strep- 
tococcal extract in a  dilution (1:200)  known to provide a  high degree of opalescence.  After 
measurement of the opalescence produced, 5 ml of each mixture was placed in a  capped 6.5 
ml  lusteroid centrifuge tube  with the aid  of a  hypodermic syringe and  23  gauge cannula. 
Tubes were filled to capacity with 0.15  i  NaCI,  plugged, and centrifuged at 40,000 •PM  for 
18 hours. Upon completion of the run, each tube showed 3 distinct zones: an uppermost thin 
milky layer, a clear intermediate zone representing about two-thirds of the total volume, and 
a  lower straw-colored zone of sedimented protein. Tubes were sliced  about  1 cm below the 
top layer and, by several washings of the upper section of the tube with saline,  the floating 
material was quantitatively recovered in the same volume (5 ml) as that of the original mix- 810  REI,EASE  OF  CIIOLESTEROL  ESTERS  FROM  1.IPOPROTEINS 
ture placed in the tube. The opalescence of each recovered low density fraction was measured 
against a control  preparation derived  from a serum buffer mixture  that had been incubated 
and fractionated in parallel with the corresponding  serum extract mixture.  In addition, the 
low  density fraction from  one  of  the  incubated  extract serum  mixtures  (horse  1 88)  was 
subjected to paper electrophoresis after prestaining for lipoprotein.  Included  in the same run 
were prestained samples  of  the  unfractionated  test  and  control  mixtnres  containing  this 
particular serum. 
As shown by the data in Table I, ultracentrifugal itotation at  normal sermn 
density  provides  effective  separation  of  the  products  responsible  for  opal- 
escence.  Thus,  the floatable fraction exhibited 92  to  100  per cent of the opal- 
FIG. 1.  Lipid patterns following paper electrophoresis of A, horse serum  1-88 incubated at 
37°C for 24 hours with buffer (no streptococcal extract); B, same horse serum incubated with 
streptococcal extract (unfractioned  mixture); C, ultracentrifugally derived opalescent fraction 
of B. All samples were prestained with acetylated Sudan black. 
escence of the unfractionated reaction mixtures while the infranatant fraction 
was,  in  all cases, crystal clear. This result is consistent with  the  concept  thai 
lipoidal products are responsible for opalescence in  extract-treated sera. That 
the streptococcal extract affects a~-lipoprotein of horse serum,  and  that  ultra- 
centrifugal  flotation  provides  a  clean-cut  isolation  of  low  density  lipoidal 
products  is  evident  from  the  lipid-stained paper  electrophoretic patterns  of 
Fig. 1.  Following incubation of horse serum with  the extract there is complete 
disappearance of the al-lipoprotein band  with  a  concomitant accumulation  of 
sudanophilic  material  in  the  region  of  the  origin,  and  the  appearance  of  a 
faint new band of lipoidal material in the region between c~1- and ~-lipoprotein. 
The  ultracentrifugally  separated  opalescent  fraction,  concurrently  subjected 
to  electrophoresis, shows  material at  the  origin with  a  strong  affinity for  tile 
Sudan  stain;  it  otherwise  appears  free  of  the  normal  lipid-containing 
components  of  the  serum.  The  absence  from  this  fraction  of  the  new  mobile 
component  of  the  extract-treated  serum,  noted  above,  suggests  that  this 
component  may  represent  a  high  density product  of  extract  action.  Electro- R.  gOWXN  811 
phoretograms  of  floatable  fractions  separated  from  control  sera  incubated 
without  extract do not  show non-migrating lipoidal material. 
Chemical Characterization of the Low Density Reaction Products 
Examination of the fraction recovered by ultracentrifugal flotation seemed 
to offer an excellent opportunity to identify and measure one or more of the 
products of the action of the streptococcal extracts on serum. It was necessary 
to consider, however,  that the recovered fraction might also contain traces of 
normally  occurring  low  density  lipoproteins  (11),  and  possibly products  of 
lipoprotein degradation arising independently of the action of the streptococcal 
extract  (12).  Hence,  in obtaining information concerning the chemical nature 
of the low density reaction products, concurrent analyses were made as routine 
of fractions prepared from sera incubated with and without  extract. 
Fresh samples of one human and two horse sera were cleared of material floatable at normal 
serum density by preliminary ultracentfifugation under conditions  identical with those used 
for the recovery of low density reaction products. The small amount of floatable material in 
each case was discarded and the remaining serum brought to the original volume with 0.15 
M  NaC1. The total cholesterol and phospholipid contents of these sera, in mg per 100 ml were 
77.8 and  155.6 for horse  1-55; 62.6 and  123.4 for horse  1-75; 164 and  194.4 for the human 
serum.  Twenty ml  of  each of these prepared scra were incubated at 37°C with 0.2 ml of 
streptococcal extract in 0.1 M sodium acetate, or with 0.2 ml of the acetate solution as con- 
trol; test and control mixtures were at pH 7.3-7.5. Opalescence, measured  on small aliquots 
of test mixtures,  was nearly maximal by 3 hours. Mter 6 hours at 37°C definitive determina- 
tion of opalescence was made, and dupficate 5 ml samples of all incubated mixtures fractionated 
by ultracentrifugation as in the preceding experiment.  Mter tube sectioning, the upper frac- 
tion in each tube was quantitatively recovered and adjusted to a  volume of 5 ml. The pre- 
pared fractions were analyzed for total lipid, unesterified  and total cholesterol,  lipid phos- 
phorus,  and total nitrogen.  Direct protein analyses were not carried out because,  in trials 
using several commonly employed methods,  the opalescence and fatty nature of the fraction 
recovered  from  extract-treated sera had  been found  to interfere with such  analyses.  Un- 
esterified fatty acids were not measured  since previous tests had indicated their virtual ab- 
sence from the ultracentrifugally recovered products. 
Table II shows the composition of the low density fractions obtained from 
the two samples of horse serum and the sample of human serum incubated in 
the presence and  absence of the  streptococcal extract.  As the fractions from 
each  extract-treated  serum  and  its  control  were  concurrently  prepared  and 
analyzed,  the  difference may  be  taken  as  a  valid  representation  of  the  low 
density products released through the action of the extract. Cholesterol esters 
represented  the major reaction product,  and actually comprised 85  to 90 per 
cent of the total low density lipid released. Moreover, the liberated cholesterol 
accounted  for  a  sizeable part  of  the  total cholesterol  present in  the  original 
sera: 18 per cent in the case of the human serum,  and 75  and 92 per cent for 
the  horse  sera.  Unesterified  cholesterol  was  in  no  instance  detected  in  the 
low density product fractions of the  incubated mixtures. On  the other hand, 812  RELEASE  OF  CHOLESTEROL  ESTERS  FROM  LIPOPROTEINS 
some phospholipid was apparently released through the action of the extract; 
the amount (4.5 to 12.8 mg per cent) was relatively small, representing 7 to 12 
per cent of the total low density lipid released, or 2 to 10 per cent of the total 
serum phospholipid. Although the values for total lipid are of limited accuracy, 
they nevertheless tend to indicate that esterified cholesterol and phospholipid 
probably are  the  only lipids present in significant concentration among the 
low  density products.  A  small amount of lipid  unaccounted for in  the  low 
density products from the human serum may represent released triglyceride, 
TABLE  II 
Effect of Streptococcal  Extract on Serum as Reflected by Changes in the Chemical  Composition of 
the Fraction  Obtained  by  Ultracentrifugal  Flotation  at Normal Serum Density 
lI 
III 
(.) 
(b) 
(o-b) 
(a) 
(b) 
(a-b) 
(a) 
(b) 
(a-b) 
Incubated mixture 
Horse serum 1-55  plus extract 
Horse serum 1-85  plus  diluent 
(Low density  products) 
Horse serum 1-75 plus extract 
Horse  serum 1-75 plus diluent 
(Low density  products) 
Human serum,  Der.,  plus  extract 
Human serum,  Der.,  plus  diluent 
(Low density  products) 
3 
© 
O. 86 
0.00 
0.86 
1.03 
O. O0 
1.03 
O. 93 
0.00 
0.93 
Components of  low density  fraction  (nag  per I00  ml 
native serum) 
Total lipid 
111 
3  (<10) 
ca  108 
107 
0 (<i0) 
ca  I07 
6O 
0  (<10) 
ca  60 
C.  •  IUnesteri-[ 
noJes-  I  fled  I  Phos- 
terol  ~  .  .  ~  ho- 
cnoles-  ~pid  esters  terol 
97.9  O§  17.4 
0.0  I  0  7.7 
4 
97.9  !  0  9.7 
[ 
97.1  0  21.4 
0.0  0  8.6 
97.1  0  12.8 
50.7  0  18.5 
0.0  0  14.0 
50.7  0  4.8 
Non- 
lipid 
nitro- 
gent 
I  5,5 
!  5.5 
0.0 
7.9 
7.0 
0.9 
4.8 
4.8 
0.0 
*  Expressed as  optical  density units. 
:~  Total nitrogen  minus  phospholipid  nitrogen (assuming  N/P in  phospholipid  to  be unity). 
§  Not detected;  probably  less  than Img per 100  ml. 
but  the  insensitivity of the  total lipid determination makes  this uncertain. 
The  lack  of  any  appreciable  difference  in  non-lipid  nitrogen  between  the 
fractions derived from extract-treated and control sera indicates the probable 
absence of protein from the low density reaction products. 
Although cholesterol esters  represented  the  major lipid component of the 
opalescent fraction of each of the treated sera, the amount released relative to 
the degree of opalescence differed from serum to serum. A uniform proportion- 
ality was  also lacking between opalescence and the  amount of phospholipid 
released through extract action. 
In an experiment designed to supplement the above chemical analyses, the 
lipids  in  the  floatable fraction of extract-treated  and  control  sera  were  ex- 
amined  chromatographically using  silicic  acid-impregnated  paper  and  two 
solvent systems, A and B, capable respectively of resolving phospholipids and R.  ROWAN  813 
neutral lipids. Fractions were prepared in the same manner as for the chemical 
analyses except that each was recovered in a volume one-half that of the original 
serum. 25 gl samples were directly chromatographed, along with appropriate 
reference  lipids,  and  the  chromatograms  examined  for  fluorescence  under 
ultraviolet light after staining with rhodamine-6-G. 
The resulting chromatograms (Fig. 2) show the resolution of lipids contained 
in the low density product fraction of two different extract-treated sera (horse 
and human), as well as the absence of detectable lipid in the fractions from the 
corresponding serum-buffer controls. With solvent system A, the low density 
products of the treated horse and human sera are seen to consist of abundant 
neutral lipid plus a  relatively small amount of phospholipid migrating with 
the velocity of lecithin. The patterns obtained with solvent system B established 
that all, or nearly all, of the neutral lipid consists of cholesterol esters. Tri- 
glycerides appear  to be absent from the low density products of both  sera, 
while a  trace of unesterified cholesterol is detectable in the fraction from the 
treated human serum. (Free cholesterol was never discerned among the floatable 
products of treated horse sera, nor consistently found with other samples of 
human serum exposed to the streptococcal extract.) The fluorescent material 
evident at the origin in the chromatograms of fractions of both extract-treated 
sera with solvent system B  doubtless includes the minor phospholipid com- 
ponent noted above. Though not illustrated in Fig. 2, chromatograms of the 
same fractions, developed in solvent system A  and sprayed with ninhydrin, 
failed to reveal any phosphatidyl ethanolamine or phosphatidyl serine.  The 
area of sample application did show faint ninhydrin staining of equal intensity 
with product  and control fractions, presumably due  to  traces  of protein  or 
polypeptide.  The  chromatographic  studies  thus  substantiate  the  chemical 
analyses in implicating esterified cholesterol as the prime low density product 
released by the action of the extract on serum lipoproteins. In addition, they 
affirm that phospholipid is also liberated in small amount, and indicate that 
the latter may be a single substance, namely lecithin. 
Although unesterified cholesterol  is  usually not  detected  among  the  low 
density reaction products, one cannot be certain it is not released by extract 
action. Because of its relatively high density (ca 1.06), free cholesterol, unless 
associated with other lipids, would not be recoverable by flotation at the un- 
adjusted  solution  density of  serum.  Freely dispersed  cholesterol  in  minute 
amounts is, however, extremely inhibitory to the hemolytic action of strepto- 
lysin O  (13)  and,  if present  in  significant quantity in  extract-treated  sera, 
would be expected to increase the streptolysin O inhibitory activity of these 
sera.  Streptolysin O inhibitor titrations were carried out by a  very sensitive 
procedure  (3)  on several  samples of human and horse sera before and after 
treatment  with  extract.  Elevated  titers  could  not  be  demonstrated  in  the 
extract-treated sera, suggesting that if cholesterol is released as such, it must A  DIISOBUTYL  KETONE : ACETIC ACID  : WATER 
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FIG.  2.  Chromatographic  resolution  on  silicic  acid-impregnated  paper  of phospholipids 
(solvent system  A)  and  neutral lipids  (solvent system  B)  in fractions  separated  by ultra- 
centrifugai flotation from incubated  serum-extract  and  serum-buffer mixtures.  Incubations 
were at 37°C for 6 hours; final dilution of extract 1:100.  Chromatograms  stained  with rho- 
damine-6-G were examined under ultraviolet light. Solid outlines indicate pronounced fluo- 
rescence; broken outlines, faint fluorescence  seen best on moist chromatograms. 
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undergo  rapid recombination.  Indeed,  as  will be  described in  a  later report 
(14), streptococcal extracts can augment the process of cholesterol esterificafion 
that  occurs  spontaneously  at  a  very  slow  rate  when  fresh  human  serum  is 
kept at 37°C  (15). 
Factors Influencing the Rates of Opalescence Development and 
Cholesterol Release in Extract-Treated  Serum 
In order to further characterize the interaction of the streptococcal extract 
and  serum,  kinetic  studies  were  carried  out  under  varied  conditions  of pH, 
extract concentration,  and  incubation  temperature.  Since one major purpose 
was  to  discover  the  relationship,  if  any,  between  the  development  of  opal- 
escence and  the release of cholesterol, these  two effects were compared in all 
cases. Measurement of released cholesterol at specific time intervals was made 
possible by the finding, in preliminary experiments, that the activity in extract- 
serum mixtures is arrested by acidification to pH 4.0. Horse serum was chosen 
as "substrate"  for  these studies because the bulk of its cholesterol is able to 
be liberated by the  action of the  extract; moreover,  incubated horse  serum- 
buffer mixtures  rarely contain  any cholesterol floatable under  the  conditions 
used to recover low density reaction products.  Specially stabilized serum was 
used throughout to prevent the spontaneous increases in pH that might other- 
wise occur on incubation through  the loss of CO,  (16). 
Effect of pH.-- 
A large sample of horse serum was first stabilized by repeated adjustment to pH 6.5 with 
N HC1, with removal of released CO2 under partial vacuum at room temperature after each 
adjustment. This serum, which remained at pH 6.5 after being subjected to reduced pressure 
for 1 hour,  finally was filtered through sintered glass of fine porosity. Five 40 ml portions were 
individually adjusted to a particular pH in the range 4.0 to 8.0 by the addition of N HC1 or 
N NaOH, and the small volume increments equalized with 0.15 x~ NaC1. 20 ml of serum  at 
each pH was mixed with 5 ml  of a  1:20 dilution of streptococcal extract in  0.2 M buffer 
(acetate for pH 4.0 and 5.0; phosphate for pH 6.0 and 7.0; tris for pH 8.0), and incubated 
at 37°C. A control mixture containing buffer in place of diluted extract was prepared at each 
pH and incubated concurrently. Aliquots were taken from  test and control mixtures after 
1 and 2 hours at 37°C for measurement  of opalescence (1 ml)  1 and cholesterol release  (5 ml). 
Samples  for the latter determination were immediately adjusted to pH 4.0, and ultracen- 
trifuged as described above for the recovery of low density reaction products. By appropriately 
accounting for dilution, the amount of esterified cholesterol recovered by floatation could be 
expressed in terms of 100 ml of the original serum. As cholesterol was found only in the frac- 
tions from serum-extract mixtures,  no correction for the control was necessary in calculating 
the amount released through extract action. 
1 For convenience, optical density was measured without changing the pH of the mixtures. 
Control experiments  indicated that bringing all samples to a  common  pH would not have 
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The data in Fig. 3 show that the interaction of streptococcal  extract and 
horse serum proceeds effectively over the range of pH 5.0 to 8.0, but is scarcely 
detectable at pH 4.0. In the pH 5.0-8.0  reaction  mixtures,  the opalescence 
produced and cholesterol released during the  1st hour of incubation parallel 
one another, with both effects maximal at pH 6.0.  2 During the 2nd hour of 
incubation, however,  the  rate  of opalescence development in each reaction 
mixture falls off sharply compared  with the rate of cholesterol  release. The 
divergence is greatest in the mixture (pH 6.0) with the highest initial reaction 
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Fro. 3.  Opalescence production and cholesterol release as a function of pH. Determinations 
were made after incubation of individual mixtures at 37°C for 1 and 2 hours. Final dilution of 
extract in all cases, 1:100. 
rate  where,  during  this  period,  the amount of released  cholesterol  is  doubled 
while opalescence is increased only about 10 per cent. After 2 hours of incuba- 
tion a  higher degree of opalescence is, in fact,  attained  at pH 7.0 than at pH 
6.0. 
In a supplementary test in which a sample of the same serum was incubated 
with the extract in a  final dilution of 1:10 instead of 1:100, the divergence at 
pH  6.0  was  even  more  pronounced.  Cholesterol  release  in  this  case  was  es- 
sentially complete (33.1 mg per cent) after  1 hour of incubation,  whereas,  the 
opalescence produced amounted to only 0.30 optical density units, as compared 
to 0.50 for the corresponding mixture (see Fig. 3) with the more dilute extract. 
2 Experiments with mixtures differing by only 0.4 pH unit indicate that the true optimum 
is closer to pH 5.8 than to pH 6.0. ~.  ROWEN  817 
This  result  recalls  Krumwiede's  finding  of  diminished  opalescence  at  high 
extract  concentration despite  maximal  alteration  in  the  electrophoretic dis- 
tribution of serum lipids. 
Effect of Extract  Co~wcntration.--Since  the relationship between opalescence 
and cholesterol release is evidently profoundly influenced by extract concen- 
tration, the progress of the two induced changes in serum with time was system- 
atically compared at several different concentrations of streptococcal extract. 
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FIo.  4.  Time course  of opalescence  production in comparison to  cholesterol  release  as a 
function of extract concentration.  Serum-extract mixtures (pH 5.8)  were incubated at 37°C. 
The  experimental  procedure  followed  that  of  the  previous  experiment  except  that  all 
serum-extract mixtures were incubated at pH 5.8,  ~ and the final concentration of extract was 
varied from  1:250  to  1:2000.  At 0  time,  and after several intervals  of incubation at  37°C, 
opalescence  was measured and a  portion of each reaction  mixture immediately adjusted  to 
pH 4.0 for subsequent estimation of released cholesterol. 
The  results  (Fig.  4)  indicate  that  opalescence production and  cholesterol 
release do not follow a completely parallel course in any of the reaction mixtures. 
The deviation between the two effects appears earlier and is more pronounced 
as the concentration of extract is increased. With the higher concentrations of 
extract, cholesterol release continues at a high rate after opalescence has levelled 818  RELEASE  OF  CHOLESTEROL ESTERS FRO~  LIPOPROTEINS 
off considerably. The  implications of  these  and  other  data pertaining  to  the 
discrepancy  between  opalescence production  and  cholesterol  release  will  be 
considered in the Discussion. 
E~ect  of  Temperature.--The  initial  rates  of  opalescence  production  and 
cholesterol release were further compared as a  function of incubation temper- 
ature. Experimental conditions were chosen (optimal pH, high extract concen- 
tration) so as to provide sufficient cholesterol release for accurate measurement 
at an early period in  the reaction. 
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FIG. 5.  Comparison of initial rates of opalescence production and of cholesterol release a 
a function of incubation temperature. All mixtures were at pH 5.8 and contained streptococca 
extract in a final dilution of 1:250. 
Replicate mixtures comprising 20 ml of stabilized horse serum at pH 5.8 and 5 ml of 1:50 
streptococcal extract buffered at the same pH were incubated at different temperatures, from 
20°-55°C. Released cholesterol was measured at i hour and opalescence at 10 minute intervals 
during the hour.  A preliminary plot of the opalescence values ~ersus time showed some de- 
parture from linearity after the first 20 minutes in mixtures incubated above 40°C. Therefore, 
values for an earlier 10 minute interval were used to represent the initial rates of opalescence 
production. 
It is evident from the temperature-activity curves in Fig. 5  that  the initial 
rates  of  opalescence  production  and  cholesterol  release  are  temperature- 
dependent,  and  run  roughly  parallel  in  mixtures  incubated  over  the  range 
20°-55°C.  From  20°-30°C  opalescence  production  appears  more  responsive 
than  cholesterol release  to  temperature  change.  However,  the  rates for  both 
effects show an equally sharp increase (about 1.5-fold) between 35 ° and 40°C; 
an optimum between 45 ° and 50°C;  and a  precipitous decline at 55°C.  These 
similarities, as well as those noted in  the  experiment involving alterations in 
pH,  are  evident at  concentrations  of extract where  opalescence development 
and cholesterol release do not follow a  parallel course throughout an extended 
reaction period  (see Fig. 4).  Thus,  it would  seem  that  the  two  effects are in R.  ROWEN  819 
fact closely related and, though subject to secondary modification,  are probably 
expressions  of a  single basic reaction. All of the data are consistent with the 
idea that this underlying reaction is enzymic in nature with clearly defined pH 
and temperature optima. 
DISCUSSION 
That human and animal sera may be optically clear despite a relatively high 
lipid content is owing to the intimate association of these lipids with specific 
serum proteins.  Theoretically, opalescence could result from denaturation  or 
degradation of the lipoprotein complexes with exposure or release of the water- 
insoluble  lipids.  The  present  experiments  provide  direct  chemical  evidence 
that  extracts of certain  Group A streptococci cause opalescence in serum by 
setting  free  particular  lipids  from  one  or  more  serum  lipoproteins.  These 
liberated  lipids,  recoverable  by  ultracentrifugal  flotation  at  normal  serum 
density, consist for the most part of cholesterol  esters accompanied by a small 
amount of phospholipid (probably lecithin). Visual  inspection of lipid-stained 
electrophoretograms  of extract-treated  sera  suggests  that  these  lipids  come 
from ~l-lipoprotein.  This is supported by unpublished  experiments  (17)  em- 
ploying ultracentrifugation  at  elevated solution densities  (18)  to fractionate 
the lipoproteins of extract-treated human serum. These experiments indicate 
that  the floatable products are derived almost exclusively from high density 
(d  >  1.063)  lipoprotein--which  corresponds  to  al-lipoprotein.  The  present 
findings  disagree,  however, with the concept of total or indiscriminate release 
of lipids from arlipoprotein  suggested by Krumwiede  (2).  The  low density 
product  fractions  of extract-treated  sera do not  contain  the  full variety of 
lipids  in  al-lipoprotein,  nor  do  they  have  a  cholesterol/phospholipid  ratio 
characteristic of any serum lipoprotein (19, 20). The disappearance of sudan- 
ophilic  material  from  the  al-lipoprotein  region  on  electrophoretograms  of 
extract-treated  sera is not evidence for the complete depletion of lipid from 
al-lipoprotein;  it could be the  result  of partial  loss  of lipid  with  decreased 
mobility of the residue. 
Although  the opalescence  produced by extract-serum  interaction  is caused 
by specific low density lipids released from lipoprotein, the extent of opalescence 
development and the amount of the major lipid released (esterified cholesterol) 
do not correspond perfectly. If liberated cholesterol esters are responsible for 
opalescence, factors in addition to concentration must be involved, for example, 
factors influencing  the  state  of lipid  aggregation.  The  finding  that  the  dis- 
crepancy between the  two effects is  greatest  at  high  extract  concentration 
suggests that  the available extracts may contain some substance interfering 
with the full expression  of opalescence.  Notwithstanding  the imperfect paral- 
lelism  between opalescence production  and  cholesterol  release,  the  two phe- 
nomena appear to be closely related, and brought about by a specific enzymic 820  RELEASE  OF CHOLESTEROL  ESTERS  FROM  LIPOPROTEINS 
alteration of a  limited class of serum lipoproteins. One possibility is that the 
alteration is due to the direct action of a  streptococcal enzyme or  "lipopro- 
teinase."  Krumwiede  reached  this  conclusion  although  she  could  show  no 
effect of the extracts on crude preparations of arlipoprotein from horse serum 
unless  serum  albumin  was  present.  In  several  exploratory experiments,  we 
likewise have detected little or no action of the extracts on ultracentrifugally 
or electrophoretically isolated serum lipoproteins, or on commercially prepared 
Cohn fractions of human  and  bovine serum?  Some subtle  alteration during 
purification  might  have  rendered  these  lipoproteins  resistant  to  enzymic 
attack.  However, one must also consider the possibility that serum (or crude 
preparations of serum albumin) may contain a  lipoprotein-degrading enzyme 
in zymogen form activated by a  streptococcal factor in a  manner  analogous 
to the activation of plasminogen by streptokinase  (21). Alternatively, serum 
may supply some substance required to activate a streptococcal proenzyme or 
to bind some product of extract action; e.g.,  in the way that serum albumin 
binds liberated fatty acids in the clearing of lipemic sera by lipoprotein lipase 
(22).  Considering the inability to choose between the various possibilities at 
present,  Krumwiede's designation  of  the  streptococcal factor as  a  "lipopro- 
teinase" seems premature. 
Although the mechanism of action of the streptococcal extracts is not known, 
the reaction itself appears unique. The opalescence brought about in certain 
animal sera by a-toxin of Clostridium welchii differs markedly in that a-toxin 
hydrolyzes the lecithin and  sphingomyelin components of serum lipoproteins 
(23), as a consequence of which a broad spectrum of lipids, as well as protein, 
is found among the floatable products (24). Alterations in serum lipoproteins 
produced  by  certain  Gram-negative bacteria,  proteolytic enzymes,  or  acids 
and alkalies (13, 25) also differ from those produced by streptococcal extracts 
since the pronounced elevations in streptolysin O inhibitory activity caused by 
the former agents are not evident in sera treated with streptococcal extract. 
The prominent and  disproportionate release of esterified cholesterol through 
extract action doubtless is  related to the manner in  which cholesterol esters 
are held within the substrate lipoproteins. If, because of the non-polar nature 
of the sterol esters, weak forces of the van der Waals variety are involved (26), 
an enzymically induced lesion in some part of the lipoprotein, not necessarily 
involving the cholesterol esters themselves, might cause a  disorganization of 
the complex with a "spilling out" of esterified cholesterol. This could especially 
be the case if, as suggested by Gould (27), cholesterol esters are held within 
lipoproteins as the "guest" portion of an inclusion complex. The experimental 
fact that  a  small  amount of phospholipid  always  accompanies the  esterified 
cholesterol set free by extract-serum interaction may be a clue to the possible 
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site of enzymic attack. Conceivably, since phospholipids have both polar and 
non-polar  groups,  the  phospholipid  recovered  in  the  low  density  product 
fraction may have originally served as a "link" between cholesterol esters and 
protein within the lipoprotein complex. Enzymic rupture of the bond between 
such phospholipid and  the protein  could fully account for the experimental 
findings and would appear  to be a  reasonable working hypothesis. Through 
better understanding of the action of the streptococcal factor and of the exact 
nature of the lipoprotein degradation products,  valuable information might 
accrue  regarding  the  structures  of at  least  certain  serum  lipoproteins.  The 
predominant action of the extracts on high density lipoprotein already indicates 
that  these  lipoproteins  have  some  basic  structural  feature  different  from 
lipoproteins of lower density. Furthermore, the close similarity in composition 
of the low density product fractions of extract-treated human and horse  sera 
suggests  that  high density lipoproteins  of different mammalian species,  al- 
though not identical, have some specific structural elements in common with 
each other. 
As cholesterol occupies a  vital position in many physiological and patho- 
logical processes, any biological system capable of liberating bound cholesterol 
from  serum  (and  perhaps  tissue)  lipoproteins  deserves  close  attention.  The 
streptococcal  system is  of fundamental significance in  this  respect,  even  if 
only as  a  model  for  other  cholesterol-releasing  systems  that  may exist  in 
nature. Of possible relevance is the fact that human serum regularly contains, 
in small amount, a lipoprotein fraction of density greater than 1.21 that has 
been characterized as having little or no cholesterol (28). It is tempting to ask 
whether this represents arlipoprotein from which cholesterol has been set free 
by a  cholesterol-releasing system similar to  that involving the streptococcal 
factor. 
Finally, the significance of the streptococcal factor in relation to the patho- 
genesis of human Group A streptococcal infections merits evaluation. In one 
survey carried out in our laboratory, examination of approximately 100 strains 
of Group A streptococci from human sources revealed at least 25 strains able 
to produce opalescence in horse serum. In a  different type of survey, a  sub- 
stance capable  of inhibiting opalescence by streptococcal  extracts,  and pre- 
sumed to be antibody (2),  was detected in the sera of 25  to 30 per cent of 
apparently healthy adults, suggesting prior contact of these individuals with 
the  streptococcal factor or some immunologically related material. Thus,  it 
seems likely that in the course of some streptococcal infections the opalescence- 
producing factor is elaborated in vivo where it may exert a deleterious effect on 
certain serum lipoproteins. Experiments in progress demonstrate that  opales- 
cent plasma can be produced in experimental animals by the parenteral admin- 
istration of either streptococcal extracts or the living streptococci from which 
they are derived. 822  RELEASE  OF  CHOLESTEROL ESTERS  FRO~  LIPOPROTEINS 
SU~[MARY 
A chemical explanation has been provided for the production of opalescence 
in human and animal sera by extracts of certain Group A streptococci. Opal- 
escence results from the  selective liberation  of specific lipids  from al-serum 
lipoprotein.  The released lipids  have been quantitatively separated  through 
the relatively simple technique of ultracentrifugal flotation, and subsequently 
analyzed  by  chemical  and  chromatographic  means.  Esterified  cholesterol 
constitutes by far the major low density reaction product,  accounting for 85 
to  90 per  cent  of  the  total  lipid  released.  A  small  amount  of phospholipid 
(apparently limited to lecithin) was the only other lipid consistently found in 
low density product fractions. 
Comparative  kinetics  of  opalescence development and  cholesterol  release 
under varying conditions of pH, extract concentration, and temperature reveal 
that the two effects do not run exactly parallel but are, nevertheless, probably 
closely  related  manifestations  of  a  specific  enzymic  degradation  of  serum 
lipoprotein.  It has  been suggested  that  enzymic action may occur at  a  site 
within the lipoprotein remote from the cholesterol esters themselves. Although 
the over-all reaction appears to be mediated by an enzyme present in many 
Group  A  streptococci, it  is  uncertain  whether  this  enzyme acts  directly on 
lipoprotein or acts by causing the activation of a serum enzyme which in turn 
attacks  the lipoprotein. 
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